Terns Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 8.19 M | $331.05 M | 47.61% | 8.94% |
| MORGAN STANLEY | 02/13/2026 | 7.95 M | $321.00 M | 4.70% | 8.66% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 5.55 M | $224.22 M | 40.90% | 6.05% |
| VANGUARD GROUP INC | 01/29/2026 | 5.52 M | $223.17 M | 21.14% | 6.02% |
| VIVO CAPITAL, LLC | 02/13/2026 | 5.35 M | $216.02 M | -22.46% | 5.83% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 4.50 M | $181.80 M | 100.00% | 4.91% |
| AVORO CAPITAL ADVISORS LLC | 03/16/2026 | 4.35 M | $175.74 M | 100.00% | 4.74% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 3.38 M | $136.50 M | 100.00% | 3.69% |
| CITADEL ADVISORS LLC | 02/17/2026 | 3.17 M | $127.93 M | 99.24% | 3.45% |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | 02/17/2026 | 3.05 M | $123.03 M | 100.00% | 3.32% |
| HOLOCENE ADVISORS, LP | 02/17/2026 | 2.78 M | $112.13 M | 100.00% | 3.03% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 2.73 M | $110.35 M | 113.81% | 2.98% |
| LORD, ABBETT & CO. LLC | 02/13/2026 | 2.71 M | $109.58 M | 100.00% | 2.96% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 2.15 M | $86.99 M | -71.53% | 2.35% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.10 M | $84.72 M | 22.29% | 2.29% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 1.89 M | $76.53 M | 100.00% | 2.07% |
| STATE STREET CORP | 02/13/2026 | 1.78 M | $71.75 M | 10.60% | 1.94% |
| JPMORGAN CHASE & CO | 02/11/2026 | 1.77 M | $71.63 M | 159.70% | 1.93% |
| ACORN CAPITAL ADVISORS, LLC | 02/17/2026 | 1.75 M | $70.55 M | -11.41% | 1.90% |
| NEARWATER CAPITAL MARKETS, LTD | 02/17/2026 | 1.70 M | $68.87 M | 100.00% | 1.86% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 1.60 M | $64.49 M | 872.20% | 1.74% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 1.58 M | $63.75 M | 42.83% | 1.72% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 02/13/2026 | 1.52 M | $61.22 M | 100.00% | 1.65% |
| COMMODORE CAPITAL LP | 02/17/2026 | 1.48 M | $59.59 M | -74.12% | 1.61% |
| TORONTO DOMINION BANK | 02/17/2026 | 1.40 M | $56.59 M | 100.00% | 1.53% |
| WOODLINE PARTNERS LP | 02/17/2026 | 1.38 M | $55.64 M | 371.58% | 1.50% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 1.29 M | $52.04 M | 1,286.52% | 1.40% |
| CANDRIAM S.C.A. | 04/30/2026 | 1.26 M | $51.00 M | -46.70% | 1.38% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 1.25 M | $50.41 M | -14.33% | 1.36% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.15 M | $46.62 M | 100.00% | 1.26% |
| NUVEEN, LLC | 02/12/2026 | 1.08 M | $43.56 M | -26.82% | 1.18% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.06 M | $42.94 M | 94.39% | 1.16% |
| CAPITAL INTERNATIONAL INVESTORS | 02/11/2026 | 1.06 M | $42.82 M | 100.00% | 1.16% |
| FMR LLC | 02/17/2026 | 1.03 M | $41.49 M | 1,601.51% | 1.12% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 987.31 K | $39.89 M | 4.86% | 1.08% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 974.31 K | $39.36 M | 934.60% | 1.06% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 950.00 K | $38.38 M | 100.00% | 1.04% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 891.90 K | $36.03 M | 100.00% | 0.97% |
| MARSHALL WACE, LLP | 02/13/2026 | 878.58 K | $35.49 M | 100.00% | 0.96% |
| FIRST TURN MANAGEMENT, LLC | 02/13/2026 | 872.05 K | $35.23 M | 100.00% | 0.95% |
| SAMLYN CAPITAL, LLC | 02/17/2026 | 814.88 K | $32.92 M | 100.00% | 0.89% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/17/2026 | 810.29 K | $32.74 M | 100.00% | 0.88% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 788.66 K | $31.86 M | 211.22% | 0.86% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 769.05 K | $31.07 M | -89.74% | 0.84% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/17/2026 | 754.24 K | $30.47 M | -60.13% | 0.82% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 750.00 K | $30.30 M | 100.00% | 0.82% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 737.16 K | $29.78 M | 26.38% | 0.80% |
| NORTHERN TRUST CORP | 02/17/2026 | 664.44 K | $26.84 M | 13.09% | 0.72% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/17/2026 | 642.00 K | $25.94 M | 100.00% | 0.70% |
| ACUTA CAPITAL PARTNERS, LLC | 02/17/2026 | 637.10 K | $25.74 M | 26.71% | 0.69% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Terns Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 293 institutional investors and hedge funds held shares of Terns Pharmaceuticals Inc. The most heavily invested institutionals were:
Pictet Asset Management Holding SA: 1.66 M
UBS Group AG: 1.23 M
Nuveen, LLC: 772,592
Candriam S.C.A.: 631,636
Bank of New York Mellon Corp: 281,667
CIBRA Capital Ltd: 151,440
133.69% of Terns Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 130.19 M shares in the last 24 months. This purchase volume represents approximately $5.77 B in transactions.